Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions.Amendment #4 to Agreement • March 31st, 2005 • Boston Life Sciences Inc /De • Pharmaceutical preparations
Reference is made to the agreement between MDS Nordion Inc. (now MDS Nordion, a division of MDS (Canada) Inc.) and Boston Life Sciences Inc. dated the 9th day of August 2000 (the “Agreement”).
